Back
Trevi Therapeutics Stock Price Chart
Elon Musk Dreams, Mode Mobile Delivers
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
61
TRVI
Trevi Therapeutics
Last Price:
$4.59
Seasonality Move:
57.26%
7 Day Trial
ALL ACCESS PASS
$
7
Hidden Stock Under $5 Holds Tech World Hostage
Click here to see more.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRVI is experiencing slight buying pressure.
Trevi Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.21 | Buy |
| 20-day SMA: | 3.79 | Buy |
| 50-day SMA: | 3.28 | Buy |
| 200-day SMA: | 3.02 | Buy |
| 8-day EMA: | 4.24 | Buy |
| 20-day EMA: | 3.89 | Buy |
| 50-day EMA: | 3.48 | Buy |
| 200-day EMA: | 2.98 | Buy |
Trevi Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 70.26 | Buy |
| Chaikin Money Flow: | 287227 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.85 - 4.33) | Buy |
| Bollinger Bands (100): | (2.71 - 3.65) | Buy |
Trevi Therapeutics Technical Analysis
| Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Trevi Therapeutics Stock
Is Trevi Therapeutics Stock a Buy?
-
Trevi Therapeutics share price is 4.59 while TRVI 8-day simple moving average is 4.21, which is a Buy signal.
-
The stock price of TRVI is 4.59 while Trevi Therapeutics 20-day SMA is 3.79, which makes it a Buy.
-
Trevi Therapeutics 50-day simple moving average is 3.28 while TRVI share price is 4.59, making it a Buy technically.
-
TRVI stock price is 4.59 and Trevi Therapeutics 200-day simple moving average is 3.02, creating a Buy signal.
TRVI Technical Analysis vs Fundamental Analysis
Buy
61
Trevi Therapeutics (TRVI)
is a Buy
Is Trevi Therapeutics a Buy or a Sell?
-
Trevi Therapeutics stock is rated a BuyThe current Trevi Therapeutics [TRVI] share price is $4.59. The Score for TRVI is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
Trevi Therapeutics Stock Info
Market Cap:
352.8M
Price in USD:
4.59
Share Volume:
574.5K
Trevi Therapeutics 52-Week Range
52-Week High:
4.68
52-Week Low:
1.27
Buy
61
Trevi Therapeutics (TRVI)
is a Buy
Trevi Therapeutics Share Price Forecast
-
What is the Trevi Therapeutics stock price today?The Trevi Therapeutics stock price is 4.59 USD today.
-
Will TRVI stock go up or go down?Trevi Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Trevi Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Trevi Therapeutics is not overvalued.
Is Trevi Therapeutics Stock a Buy?
-
Trevi Therapeutics share price is 4.59 while TRVI 8-day exponential moving average is 4.24, which is a Buy signal.
-
The stock price of TRVI is 4.59 while Trevi Therapeutics 20-day EMA is 3.89, which makes it a Buy.
-
Trevi Therapeutics 50-day exponential moving average is 3.48 while TRVI share price is 4.59, making it a Buy technically.
-
TRVI stock price is 4.59 and Trevi Therapeutics 200-day simple moving average is 2.98, creating a Buy signal.
Fundamental Analysis of Trevi Therapeutics
Is Trevi Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.00 per share, and a decrease next year of $0.04 per share.
Technical Analysis of Trevi Therapeutics
Should I short Trevi Therapeutics stock?
-
TRVI Moving Average Covergence Divergence (MACD) indicator is 0.35, suggesting Trevi Therapeutics is a Buy
-
Trevi Therapeutics Relative Strength Index (RSI) is 70.26, which suggest Trevi Therapeutics is overbought
-
The Bollinger Bands (25) for Trevi Therapeutics is (2.85 - 4.33), which suggest Trevi Therapeutics is a Buy
-
The Bollinger Bands (100) for Trevi Therapeutics is (2.71 - 3.65), which suggest Trevi Therapeutics is a Buy
* Trevi Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.